Pacific Channel backs Orbis Diagnostics’ pre-Series A round of up to $11 million

• Orbis Diagnostics is raising up to $11 million in a pre-Series A private financing to fund development of its Pulse point-of-care diagnostics platform.
• Pacific Channel is a cornerstone investor in the round alongside two overseas high-net-worth individuals.
• Proceeds target Pulse 1.0 completion, strategic international partnerships, molecular testing R&D, US commercialization preparations.
• Orbis is developing a triple-panel hepatitis B point-of-care blood test using a compact instrument with a proprietary disposable disc.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacific Channel Ltd published the original content used to generate this news brief on August 25, 2026, and is solely responsible for the information contained therein.